Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hust

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
Viruses|November 25, 2023
Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of ConcernsLeila Abassi, Federico Bertoglio, Željka Mačak Šafranko, et al.
Cell Reports|May 12, 2023
Cell-surface anchoring of Listeria adhesion protein on L. monocytogenes is fastened by internalin B for pathogenesisDongqi Liu, Xingjian Bai, Harrison D B Helmick, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2025
Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activityFranziska Baatz, Arnab Ghosh, Jessica Herbst, et al.
Science Advances|May 26, 2023
Microglia mediate neurocognitive deficits by eliminating C1q-tagged synapses in sepsis-associated encephalopathyHa-Yeun Chung, Jonathan Wickel, Nina Hahn, et al.
Clinical Therapeutics|February 7, 2026
Phase I Study Evaluating a Monoclonal Fc-Silenced SARS-CoV-2 Antibody in Patients With Moderate-to-Severe COVID-19Maddalena Marconato, Christopher Hackenbruch, Simon Jäger, et al.
Nature Communications|May 13, 2022
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variantFanglei Zuo, Hassan Abolhassani, Likun Du, et al.
Plant Biotechnology Journal|November 13, 2025
Phage Display Derived Antibodies Against Antimicrobial Peptide FsPDF2 Reveal Stress Response in European BeechPhilip Alexander Heine, Tetyana Nosenko, Sarah Kistner, et al.
Med (New York, N.Y.)|February 16, 2021
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infectionNatalia Sherina, Antonio Piralla, Likun Du, et al.
BMC Medicine|March 3, 2022
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variantMaren Schubert, Federico Bertoglio, Stephan Steinke, et al.
Journal of Medical Virology|August 9, 2022
The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockadeUlf Martin Geisen, Ruben Rose, Franziska Neumann, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Viruses|November 25, 2023
Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of ConcernsLeila Abassi, Federico Bertoglio, Željka Mačak Šafranko, et al.
Cell Reports|May 12, 2023
Cell-surface anchoring of Listeria adhesion protein on L. monocytogenes is fastened by internalin B for pathogenesisDongqi Liu, Xingjian Bai, Harrison D B Helmick, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2025
Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activityFranziska Baatz, Arnab Ghosh, Jessica Herbst, et al.
Science Advances|May 26, 2023
Microglia mediate neurocognitive deficits by eliminating C1q-tagged synapses in sepsis-associated encephalopathyHa-Yeun Chung, Jonathan Wickel, Nina Hahn, et al.
Clinical Therapeutics|February 7, 2026
Phase I Study Evaluating a Monoclonal Fc-Silenced SARS-CoV-2 Antibody in Patients With Moderate-to-Severe COVID-19Maddalena Marconato, Christopher Hackenbruch, Simon Jäger, et al.
Nature Communications|May 13, 2022
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variantFanglei Zuo, Hassan Abolhassani, Likun Du, et al.
Plant Biotechnology Journal|November 13, 2025
Phage Display Derived Antibodies Against Antimicrobial Peptide FsPDF2 Reveal Stress Response in European BeechPhilip Alexander Heine, Tetyana Nosenko, Sarah Kistner, et al.
Med (New York, N.Y.)|February 16, 2021
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infectionNatalia Sherina, Antonio Piralla, Likun Du, et al.
BMC Medicine|March 3, 2022
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variantMaren Schubert, Federico Bertoglio, Stephan Steinke, et al.
Journal of Medical Virology|August 9, 2022
The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockadeUlf Martin Geisen, Ruben Rose, Franziska Neumann, et al.
Pageof 17